Browse > Article
http://dx.doi.org/10.4333/KPS.2006.36.5.321

The Effect of Enhancers on the Penetration of Albuterol through Hairless Mouse Skin  

Choi, Han-Gon (College of Pharmacy, Yeungnam University)
Rhee, Jong-Dal (College of Pharmacy, Yeungnam University)
Yu, Bong-Kyu (College of Pharmacy, Yeungnam University)
Kim, Jung-Ae (College of Pharmacy, Yeungnam University)
Kwak, Mi-Kyung (College of Pharmacy, Yeungnam University)
Woo, Jong-Soo (College of Pharmacy, Yeungnam University)
Oh, Dong-Hun (College of Pharmacy, Yeungnam University)
Han, Myo-Jung (College of Pharmacy, Yeungnam University)
Choi, Jun-Young (College of Pharmacy, Yeungnam University)
Piao, Mingguan (College of Pharmacy, Yeungnam University)
Yong, Chul-Soon (College of Pharmacy, Yeungnam University)
Publication Information
Journal of Pharmaceutical Investigation / v.36, no.5, 2006 , pp. 321-329 More about this Journal
Abstract
Albuterol, a selective ${\beta}_2$-adrenergic receptor stimulant, has been introduced as a potent bronchodilator for patients with bronchial asthma, chronic obstructive bronchial disease, chronic bronchitis and pulmonary emphysema. The percutaneous permeation of albuterol sulfate was investigated in hairless mouse skin in vitro with and without pretreatment with enhancers. The enhancing effects of ethanol and various penetration enhancers such as terpenes, non-ionic surfactants, pyrrolidones, and fatty acids on the permeation of albuterol sulfate were evaluated using Franz diffusion cells. Among terpenes studied, 1,8-cineole was the most effective enhancer, which increased the permeability of albuterol sulfate approximately 33-fold compared with the control without enhancer pretrement, followed by d-limonene with enhancement ratio of 21.79. 2-Pyrrolidone-5-carboxylic acid increased the permeability of albuterol sulfate approximately 5.5-fold compared with the control. Other pyrrolidones tested showed only slight permeability enhancing effect with enhancement ratio less than 2.8. Nonionic surfactants showed moderate enhancing effects. Lauric acid increased the permeability of albuterol sulfate approximately 30-fold with decreasing the lag time from 2.85 to 0.64 hr. Oleic acid and linoleic acid showed enhancement ratio of 24.55 and 22.91, respectively. These findings would allow a more rational approach for designing formulations for the transdermal delivery of albuterol sulfate and similar drugs.
Keywords
Albuterol; Enhancer; Transdermal drug delivery systems; Permeability;
Citations & Related Records
연도 인용수 순위
  • Reference
1 P.P. Sarpotdar and J.L. Zatz, Percutaneous absorption enhan- cement by non-ionic surfactants, Drug Dev. Ind. Pharm., 12, 1625-1647 (1986)   DOI
2 B.Y. Zaslavsky, N.N. Ossipov, V.S. Krivitch, L.P. Baholdina and S.V. Rogozhin, Action of surface-active-substances on biological membranes: II. Hemolytic activity of non-ionic surfactants, Biochim. Biophys. Acta, 507, 1-7 (1978)   DOI   ScienceOn
3 K.A. Walters, P.H. Dugard and A.T. Florence, Non-ionic surfactants and gastric mucosal transport of paraquat, J. Pharm. Pharmacol., 33, 207-213 (1981)   DOI
4 P. Ashton, K.A. Walters, K.R. Brain and J. Hadgraft, Surfactant effects in percutaneous absoption. I. Effects on the transdermal flux of methyl nicotinate, Int J. Pharm., 87, 261 (1992)   DOI   ScienceOn
5 N.S. Thomas and R. Panchagnula, Transdermal delivery of zidovudine: effect of vehicles on permeation across rat skin and their mechanism of action, Eur. J. Pharm. Sci., 18, 71-79 (2003)   DOI   ScienceOn
6 H.R. Moghimi, A.C. Williams and B.W. Barry, Enhancement by terpenes of 5-fluorouracil permeation through the stratum corneum: model solvent approach, J. Pharm. Pharmacol., 50, 955-964 (1998)   DOI   ScienceOn
7 B.J. Aungst, N.J. Rogers and E. Shefter, Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactant, sulfoxides and amides, Int. J. Pharm., 33, 225-234 (1986)   DOI   ScienceOn
8 D. Lewis and J. Hadgraft, Mixed monolayers of dipalmitoyl- phospatidylcholine with $Azone^{\circledR}$ or oleic acid at the air-water interface, Int. J. Pharm., 65, 211-218 (1990)   DOI   ScienceOn
9 B. Ongpipattanakul, R.R. Burnette, R.O. Potts and M.L. Francoeur, Evidence that oleic acid exists in a separate phase within stratum corneum lipids, Pharm. Res., 7, 350-354 (1991)
10 H. Tanojo, A. BosvanGeest, J.A. Bouwstra, H.E. Junginger and H.E. Bodde, In vitro human skin barrier perturbation by oleic acid: thermal analysis and freeze fracture electron microscopy studies, Thermochim. Acta, 293, 77-85 (1997)   DOI   ScienceOn
11 T. Ghafourian, P. Zandasrar, H. Hamishekar and A. Nokhodchi, The effect of penetration enhancers on drug delivery through skin: a QSAR study, J. Control. Rel., 99, 113-125 (2004)   DOI   ScienceOn
12 A.C. Williams and B.W. Barry, The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic (oestradiol) and hydrophilic (5-fluorouracil) drugs, Int. J. Pharm., 74, 157-168 (1991)   DOI   ScienceOn
13 H. Okabe, K. Takayama, A. Ogura and T. Nagai, Effect of limonene and related compounds on the percutaneous absorption of indomethacin, Drug Des. Delivery, 4, 313-321 (1989)
14 A.F. El-Kattan, C.S. Asbill and B.B. Michniak, The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems, Int. J. Pharm., 198, 179-189 (2000)   DOI   ScienceOn
15 B.W. Barry, Lipid-Protein-Partitioning theory of skin penetration enhancement, J. Control. Rel., 15, 237-248 (1987)
16 A. Doliwa, S. Santoyo and P. Ygartua, Effect of passive and iontophoretic skin pretreatments with terpenes on the in vitro skin transport of piroxicam, Int. J. Pharm., 229, 37-44 (2001)   DOI   ScienceOn
17 H. Okuyama, Y. Ikeda, S. Kasai, K. Imamori, K. Takayama and T. Nagai, Influence of non-ionic surfactants, pH and propylene glycol on percutaneous absorption of piroxicam from cataplasm, Int. J. Pharm., 186, 141-148 (1999)   DOI   ScienceOn
18 A. Lopez, F. Llinares, C. Cortell and M. Herr‡ez, Comparative enhancer effect of $Span^{\circledR}$ 20 with$Tween^{\circledR}$ 20 and $Azone^{\circledR}$ on the in vitro percutaneous penetration of compounds with different lipophilities, Int. J. Pharm., 202, 133-140 (2000)   DOI   ScienceOn
19 H.S. Gwak and I.K. Chun, Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxi- cam through hairless mouse skin, Int. J. Pharm., 236, 57-64 (2002)   DOI   ScienceOn
20 J. Shokri, A. Nokhodchi, A. Dashbolaghi, D. Hassan-Zadeh, T. Ghafourian and M. Barzegar Jalali, The effect of surfactants on the skin penetration of diazepam, Int. J. Pharm., 228, 99-107 (2001)   DOI   ScienceOn
21 M. Yamada and Y. Uda, Enhancement of percutaneous absorption of molsidomine, Chem. Pharm. Bull., 35, 3390 (1987)   DOI   ScienceOn
22 N.A. Megrab, A.C. Williams and B.W. Barry, Oestradiol permeation across human skin, silastic and snake skin membranes: the effects of ethanol/water co-solvent systems, Int. J. Pharm., 116, 101-112 (1995)   DOI   ScienceOn
23 J. Borras-Blasco, A. Lopez, M.J. Morant, O. Diez-Sales and M. Herraez-Dominguez, Influence of sodium lauryl sulphate on the in vitro percutaneous absorption of compounds with different lipophilicity, Eur. J. Pharm. Sci., 5, 15-22 (1997)   DOI   ScienceOn
24 B. Berner, G.C. Mazzenga, J.H. Otte, R.J. Steffens, R.H. Juang and C.D. Ebert, Ethanol: water mutually enhanced transdermal therapeutic system: II. Skin permeation of ethanol and nitroglycerin, J. Pharm. Sci., 78, 402-407 (1989)   DOI
25 C.K. Lee, T. Uchida, K. Kitagawa, A. Yagi, N. Kim and S. Goto, Skin permeability of various drugs with different lipophilicity, J. Pharm. Sci., 83, 562-565 (1994)   DOI   ScienceOn
26 B. M. Magnusson, P. Runn, K. Karlsson and L. -O. D. Koskinen, Terpenes and ethanol enhance the transdermal permeation of the tripeptide thyrotropin releasing hormone in human epidermis, Int. J. Pharm., 157, 113-121 (1997)   DOI   ScienceOn
27 K.A. Walters, A.T. Florence and P.H. Dugard, Interaction of polyoxyethylene alkyl ethers with cholesterol monolayers, J. Colloid Interface Sci., 89, 584-587 (1983)   DOI   ScienceOn
28 P.P. Sarpotdar and J.L. Zatz, Evaluation of penetration enhancement of lidocaine by non-ionic surfactants through hairless mouse skin in vitro, J. Pharm. Sci., 75, 176-181 (1986)   DOI
29 Y.D. Lee, Q.Z. Quan, S.Y. Jung, J.D. Rhee and C.S. Yong, The effect of fatty acids, fatty alcohols and propylene glycol on the penetration of clenbuterol through hairless mouse skin, J. Kor. Pharm. Sci., 29, 329-335 (1999)   과학기술학회마을
30 M.R. Prausnitz, V.G. Bose, R. Langer and J.C. Weaver, Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery, PNAS, 90, 10504-10508 (1993)   DOI   ScienceOn
31 L. Malkki and S. Tammilehto, Decomposition of salbutamol in aqueous solutions. I. The effect of pH, temperature and drug concentration, Int. J. Pharm., 63, 17-22 (1990)   DOI   ScienceOn
32 G. Rajeev, S. Cynthia, A. Lisa, S. James, S. Grant, F. Bahram and N. Thomas, Transdermal drug delivery systems of albuterol; in vitro and in vivo studies, J. Pharm. Sci., 81, 996-1000 (1982)   DOI
33 A. Lopez, F. Llinares, C. Cortell and M. Herraez, Comparative enhancer effect of $Span^{\circledR}$ 20 with $Tween^{\circledR}$ 20 and $Azone^{\circledR}$ on the in vitro percutaneous penetration of compounds with different lipophilities, Int. J. Pharm., 202, 133-140 (2000)   DOI   ScienceOn
34 R.R. Burnette In: J. Hadgraft and R.H. Guy, Editors, Ionto- phoresis, Marcel Dekker, New York, 247-291 (1989)
35 R.C. Ahrens and G.D. Smith, Albuterol: an adrenergic agent for use in the treatment of asthma pharmacology, pharmaco- kinetics and clinical use, Pharmacotherapy, 4, 105-121 (1984)   DOI
36 S. Santoyo and P. Ygartua, Effect of skin pretreatment with fatty acids on percutaneous absorption and skin retention of piroxicam after its topical application, European J. Pharm. Biopharm., 50, 245-250 (2000)   DOI   ScienceOn
37 H. Okabe, Y. Obata, K. Takayama and T. Nagai, Percutaneous absorption enhancing effect and skin irritation of monocyclic monoterpenes, Drug. Des. Delivery, 6, 229-238 (1990)
38 H. Sasaki, M. Kojima, J. Nakamura and J. Shibasaki, Enhancing effect of pyrrolidone derivatives on the transdermal penetration of 5-fluorouracil, triamcinolone acetonide, indo- methacin, and flurbiprofen, J. Pharm, Sci., 80, 533 (1991)   DOI
39 H.R. Moghimi, A.C. Williams and B.W. Barry, Enhancement by terpenes of 5-fluorouracil permeation through the stratum corneum: model solvent approach, J. Pharm. Pharmacol., 50, 955-964 (1998)   DOI   ScienceOn
40 J. Borras-Blasco, O. Diez-Sales, A. Lopez and M. Herraez-Dominguez, A mathematical approach to predicting the percutaneous absorption enhancing effect of sodium lauryl sulphate, Int. J. Pharm., 269, 121-129 (2004)   DOI   ScienceOn
41 N. Kanikkannan, K. Kandimalla, S.S. Lamba and M. Singh, Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery, Curr. Med. Chem., 7, 593-608 (2000)   DOI   ScienceOn
42 H.W. Kelly and S. Murphy, Beta-adrenergic agonists for acute, severe asthma, Ann. Pharmacother., 26, 81-91 (1992)   DOI
43 V.P. Shah, C.C. Peck and R.L. Williams In: K.A. Walters and J. Hadgraft, Editors, Pharmaceutical Skin Penetration Enhancement, Marcel Dekker, New York, 417-427 (1993)
44 K.A. Walters In: J. Hadgraft and R. Guy, Editors, Penetration Enhancers and Their Use in Transdermal Therapeutic Systems, Marcel Dekker, New York, 197-246 (1989)
45 S. Mitragotri, D. Blankschtein and R. Langer, Ultrasound-mediated transdermal protein delivery, Science, 269, 850-853 (1995)   DOI   ScienceOn
46 V.R. Sinha and M.P. Kaur, Permeation enhancers for trans- dermal drug delivery, Drug Dev. Ind. Pharm., 26, 1131-1140 (2000)   DOI   ScienceOn
47 S. Crescioli, C.A. Dal and P. Maestrelli, Controlled-release theophylline inhibits early morning airway obstruction and hyperresponsiveness in asthmatic subjects, Ann. Allergy Asthma Immunol., 77, 106-110 (1996)   DOI
48 N.R. Badcock and J.A. Leach, Albuterol: transdermal absorp- tion and fingerprick blood-sample contamination from nebuli- zers, Clin. Chem., 35, 889 (1989)
49 B. Berner, G.C. Mazzenga, J.H. Otte, R.J. Steffens, R.H. Juang and C.D. Ebert, Ethanol: water mutually enhanced transdermal therapeutic system: II. Skin permeation of ethanol and nitroglycerin, J. Pharm. Sci., 78, 402-407 (1989)   DOI
50 H.R. Moghimi, A.C. Williams and B.W. Barry, Enhancement by terpenes of 5-fluorouracil permeation through the stratum corneum: model solvent approach, J. Pharm. Pharmacol., 50, 955-964 (1998)   DOI   ScienceOn
51 P.P. Sarpotdar and J.L. Zatz, Percutaneous absorption enhance- ment by non-ionic surfactants, Drug Dev. Ind. Pharm., 12, 1625-1647 (1986)   DOI
52 A.C. Williams and B.W. Barry, Essential oils as novel human skin penetration enhancers, Int. J. Pharm., 57, R7-R9 (1989)   DOI   ScienceOn
53 K.A. Walters, A.T. Florence and P.H. Dugard, Interaction of polyoxyethylene alkyl ethers with cholesterol monolayers, J. Colloid Interface Sci., 89, 584-587 (1983)   DOI   ScienceOn
54 A. Casiraghi, P. Minghetti, F. Cilurzo and L. Montanari, In vitro skin permeation of soy isoflavones, comunication, Symposium Skin and Formulation, Paris, October, 55 (2003)
55 T.K. Ghosh, W.R. Pfister and S.I. Yum, Transdermal and Topical Drug Delivery Systems, Interpharm Press, Buffalo Grove, IL, U.S.A. (1997)
56 M.E. Johnson, D. Blankschtein and R. Langer, Evaluation of solute permeation through the stratum corneum: lateral bilayer diffusion as the primary transport mechanism, J. Pharm. Sci., 86, 1162-1172 (1997)   DOI   ScienceOn
57 A. Lopez, F. Llinares, C. Cortell and M. Herr‡ez, Comparative enhancer effect of $Span^{\circledR}$ 20 with$Tween^{\circledR}$ 20 and $Azone^{\circledR}$ on the in vitro percutaneous penetration of compounds with different lipophilities, Int. J. Pharm., 202, 133-140 (2000)   DOI   ScienceOn
58 N. Kanikkannan and M. Singh, Skin permeation enhancement effect and skin irritation of saturated fatty alcohols, Int. J. Pharm., 248, 219-228 (2002)   DOI   ScienceOn
59 D. Monti, P. Chetoni, S. Burgalassi, M. Najarro, M. Fabrizio Saettone and E. Boldrini, Effect of different terpene-containing essential oils on permeation of estradiol through hairless mouse skin, Int. J. Pharm., 237, 209-214 (2002)   DOI   ScienceOn
60 A.K. Jain, N.S. Thomas and R. Panchagnula, Transdermal drug delivery of imipramine hydrochloride: I. Effect of terpenes, J. Control. Rel., 79, 93-101 (2002)   DOI   ScienceOn
61 T. Ghafourian, P. Zandasrar, H. Hamishekar and A. Nokhodchi, The effect of penetration enhancers on drug delivery through skin: a QSAR study, J. Control. Rel., 99, 113-125 (2004)   DOI   ScienceOn
62 Y. Ota, A. Hamada, M. Nakano and H. Saito, Evaluation of percutaneous absorption of midazolam by terpenes, Drug Metab. Pharmacokin., 18, 261-266 (2003)   DOI   ScienceOn
63 A.C. Williams and B.W. Barry, Terpenes and the lipid-protein partitioning theory of skin penetration enhancement, Pharm. Res., 8, 17-24 (1991)   DOI
64 V.V. Ranade, Drug delivery systems 6: transdermal drug delivery, J. Clin. Pharmacol., 31, 401-418 (1991)   DOI
65 R.A. Biddlecombe and S. Pleasance, Automated protein precipitation by filtration in the 96-well format, J. Chro. Biomed. Appl., 734, 257-265 (1999)   DOI   ScienceOn
66 P.A. Cornwell and B.W. Barry, Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil, J. Pharm. Pharmacol., 46, 261-269 (1994)   DOI   ScienceOn
67 A.C. Williams and B.W. Barry, Transdermal oestradiol permeation: the effects of terpene penetration enhancers. In: R.C. Scott, R.H. Guy, J. Hadgraft and H.E. Bodde(Eds), Prediction of Percutaneous Penetration: Methods, Measurements, Modelling, IBC Technical Services, London, 386-393 (1991)
68 Y. Obata, K. Takayama, Y. Maitani, Y. Machida and T. Nagai, Effect of pretreatment of skin with cyclic monoterpenes on permeation of diclofenac in hairless rat, Biol, Pharm. Bull., 16, 312-314 (1993)   DOI   ScienceOn